Published in Environ Health Perspect on June 01, 2000
Identifying critical windows of exposure for children's health. Environ Health Perspect (2000) 2.32
A framework for assessing risks to children from exposure to environmental agents. Environ Health Perspect (2004) 1.09
Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J Neurochem (2007) 1.09
Risk of learning and behavioral disorders following prenatal and early postnatal exposure to tetrachloroethylene (PCE)-contaminated drinking water. Neurotoxicol Teratol (2008) 1.06
Exposure assessment implications for the design and implementation of the National Children's Study. Environ Health Perspect (2005) 1.05
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect (2001) 1.05
Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience (2013) 1.05
Prenatal p,p´-DDE exposure and neurodevelopment among children 3.5-5 years of age. Environ Health Perspect (2012) 0.95
Understanding the role of nutrition in the brain and behavioral development of toddlers and preschool children: identifying and addressing methodological barriers. Nutr Neurosci (2009) 0.95
Hazard identification and predictability of children's health risk from animal data. Environ Health Perspect (2004) 0.90
Lactational exposure to polychlorinated biphenyls, dichlorodiphenyltrichloroethane, and dichlorodiphenyldichloroethylene and infant neurodevelopment: an analysis of the pregnancy, infection, and nutrition babies study. Environ Health Perspect (2008) 0.89
The development of psychotic disorders in adolescence: a potential role for hormones. Horm Behav (2013) 0.88
Chronic intermittent ethanol exposure during adolescence: effects on social behavior and ethanol sensitivity in adulthood. Alcohol (2014) 0.88
Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: results of a World Health Organization review. Regul Toxicol Pharmacol (2013) 0.82
Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk. Crit Rev Toxicol (2014) 0.82
Tooth matrix analysis for biomonitoring of organic chemical exposure: Current status, challenges, and opportunities. Environ Res (2015) 0.78
N-acetyl cysteine treatment reduces mercury-induced neurotoxicity in the developing rat hippocampus. J Neurosci Res (2012) 0.78
A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther (2013) 0.78
Comparable measures of cognitive function in human infants and laboratory animals to identify environmental health risks to children. Environ Health Perspect (2003) 0.78
Association between body weight of newborn rats and density of serotonin transporters in the frontal cortex at adulthood. J Neural Transm (Vienna) (2005) 0.76
A Review of the Field on Children's Exposure to Environmental Contaminants: A Risk Assessment Approach. Int J Environ Res Public Health (2017) 0.75
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect (2000) 7.58
Retinoic acid embryopathy. N Engl J Med (1985) 5.85
The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neurotoxicol Teratol (1993) 3.13
Maturation of human cerebrum observed in vivo during adolescence. Brain (1991) 2.27
Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol (1996) 2.23
Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull (1989) 2.19
Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology (2000) 1.89
Low-level lead exposure and cognitive function in children. Pediatr Ann (1994) 1.83
Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol (1990) 1.67
Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology (1997) 1.48
New nerve cells for the adult brain. Sci Am (1999) 1.47
The Dutch famine and schizophrenia spectrum disorders. Soc Psychiatry Psychiatr Epidemiol (1998) 1.19
Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.18
Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol (1999) 1.17
Prenatal factors and adult mental and physical health. Can J Psychiatry (1999) 1.14
Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice. Biol Psychiatry (1999) 1.14
The use of timing behaviors in animals and humans to detect drug and/or toxicant effects. Neurotoxicol Teratol (1999) 1.10
Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies. Reprod Toxicol (1991) 1.10
Behavioral effects of lead: commonalities between experimental and epidemiologic data. Environ Health Perspect (1996) 1.08
Synaptogenesis in monkey somatosensory cortex. Cereb Cortex (1992) 1.07
Lead exposure and neurobehavioral development in later infancy. Environ Health Perspect (1990) 1.05
Evaluation of the child with idiopathic mental retardation. Pediatr Clin North Am (1992) 1.05
Animal behavior models. Increased sensitivity to stressors and other environmental experiences after prenatal cocaine exposure. Ann N Y Acad Sci (1998) 1.03
The comparative developmental neurotoxicity of lead in humans and animals. Neurotoxicol Teratol (1990) 1.01
Selective vulnerability of the developing brain to lead. Curr Opin Neurol (1998) 0.98
Gestational exposure to methylmercury alters the developmental pattern of trk-like immunoreactivity in the rat brain and results in cortical dysmorphology. Brain Res Dev Brain Res (1998) 0.95
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology (1993) 0.95
Degenerative changes in the developing nervous system as a result of in utero exposure to methylmercury. Environ Res (1977) 0.93
Disruption of cerebellar maturation by an antimitotic agent impairs the ontogeny of eyeblink conditioning in rats. J Neurosci (1995) 0.91
Structure-activity and dose-response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol (1993) 0.91
Changes in the physiological roles of neurotransmitters during individual development. Neurosci Behav Physiol (1999) 0.90
Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging. Neurobiol Aging (1996) 0.90
Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands. Schizophr Res (1999) 0.89
Long-term consequences of prenatal exposure to cocaine or related drugs: effects on rat brain monoaminergic receptors. Brain Res Bull (1991) 0.87
Control of endogenous norepinephrine release in the hypothalamus of male rats changes over adolescent development. Brain Res Dev Brain Res (1997) 0.86
Chronic low-level lead exposure impairs embryonic to adult conversion of the neural cell adhesion molecule. J Neurochem (1987) 0.86
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol Teratol (1990) 0.84
The effect of prenatal and postnatal lead exposure on neonatal synaptogenesis in rat cerebral cortex. J Toxicol Environ Health (1983) 0.84
Fetal anticonvulsant syndrome in rats: dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring. J Pharmacol Exp Ther (1983) 0.84
Reliability, sensitivity and validity of behavioral indices of neurotoxicity. Neurotoxicol Teratol (1988) 0.84
Effects of ethanol consumption by adolescent alcohol-preferring P rats on subsequent behavioral performance in the cross-maze and slip funnel tests. Alcohol (1996) 0.83
Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group II report: testing methods in developmental neurotoxicity for use in human risk assessment. Neurotoxicol Teratol (1990) 0.83
The effect of lead toxicity and milk deprivation of myelination in the rat. Toxicol Appl Pharmacol (1985) 0.82
Late developmental changes in the ability of adenosine A1 receptors to regulate synaptic transmission in the hippocampus Brain Res Dev Brain Res (1998) 0.82
Cognitive and neuroanatomical effects of triethyltin in developing rats: role of age of exposure. Brain Res (1994) 0.81
Age-related increase in auditory impairment in monkeys exposed in utero plus postnatally to methylmercury. Toxicol Sci (1998) 0.81
The influence of developmental period of lead exposure on long-term potentiation in the adult rat dentate gyrus in vivo. Neurotoxicology (1999) 0.81
Effects of gestational methylmercury exposure on immunoreactivity of specific isoforms of PKC and enzyme activity during post-natal development of the rat brain. Brain Res Dev Brain Res (1998) 0.81
Gestational retinoic acid exposure: a sensitive period for effects on neonatal mortality and cerebellar development. Neurotoxicol Teratol (1997) 0.81
Synaptogenesis in the hippocampal dentate gyrus: effects of in utero ethanol exposure. Brain Res Bull (1988) 0.80
Behavioral effects of low-dose gestational day 11-13 retinoic acid exposure. Neurotoxicol Teratol (1997) 0.79
Comparison of visual function at adulthood and during aging in monkeys exposed to lead or methylmercury. Neurotoxicology (1999) 0.79
Chronic low level lead exposure precociously induces rat glial development in vitro and in vivo. Neurosci Lett (1988) 0.79
Collaborative Behavioral Teratology Study: background and overview. Neurobehav Toxicol Teratol (1986) 0.79
Deficient cumulative learning: an animal model of retarded cognitive development. Neurotoxicol Teratol (1994) 0.79
Developmental differences in neural damage following trimethyl-tin as demonstrated with GFAP immunohistochemistry. Ann N Y Acad Sci (1993) 0.78
Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine. Psychopharmacology (Berl) (1992) 0.78
Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies. Reprod Toxicol (1991) 0.78
Morphometric effects of preweaning lead exposure on the hippocampal formation of adult rats. Neurotoxicology (1984) 0.78
Influence of exposure period on in vivo hippocampal glutamate and GABA release in rats chronically exposed to lead. Neurotoxicology (1999) 0.78
A behavioral and neuroanatomical investigation of the lethality caused by gestational day 11-13 retinoic acid exposure. Neurotoxicol Teratol (1997) 0.78
Prenatal cocaine exposure increases the reinforcing strength of oral ethanol in C57 mice. Neurotoxicol Teratol (1997) 0.77
Cognitive profile of rats exposed to lactational hyperphenylalaninemia: correspondence with human mental retardation. Dev Psychobiol (1990) 0.77
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect (2000) 7.58
Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health (1996) 7.44
Choosing a future for epidemiology: I. Eras and paradigms. Am J Public Health (1996) 5.25
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood. JAMA (1999) 3.66
Lifetime and five-year prevalence of homelessness in the United States. Am J Public Health (1994) 3.48
Lifetime and five-year prevalence of homelessness in the United States: new evidence on an old debate. Am J Orthopsychiatry (1995) 2.42
Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study. BMJ (2001) 2.42
The effects of perinatal tebuconazole exposure on adult neurological, immunological, and reproductive function in rats. Toxicol Sci (2001) 2.11
A future for epidemiology? Annu Rev Public Health (1999) 1.81
Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology (1993) 1.67
Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals. Braz J Med Biol Res (2001) 1.64
Reliability of self-reports about sexual risk behavior for HIV among homeless men with severe mental illness. Psychiatr Serv (2000) 1.61
Essential and nonessential roles for psychiatrists in community mental health centers. Hosp Community Psychiatry (1991) 1.52
The Autism Birth Cohort: a paradigm for gene-environment-timing research. Mol Psychiatry (2010) 1.51
Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol (2012) 1.50
Developmental neurotoxicity: evaluation of testing procedures with methylazoxymethanol and methylmercury. Fundam Appl Toxicol (1994) 1.44
Fever and acute brief psychosis in urban and rural settings in north India. Br J Psychiatry (1999) 1.40
Spontaneous abortion and induced abortion: an adjustment for the presence of induced abortion when estimating the rate of spontaneous abortion from cross-sectional studies. Am J Epidemiol (1983) 1.38
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry (2000) 1.36
Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action? Toxicol Appl Pharmacol (1999) 1.35
Commentary: The impact of fetal and infant exposures along the life course. Int J Epidemiol (2001) 1.34
The protective effect of condoms and nonoxynol-9 against HIV infection. Am J Public Health (1998) 1.28
Evidence-based psychotherapeutic interventions in the community care of schizophrenia. Br J Psychiatry (2001) 1.24
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol (2012) 1.23
Do hydrofluorocarbons destroy stratospheric ozone? Science (1994) 1.22
Type I and type III collagen content of healing wounds in fetal and adult rats. Proc Soc Exp Biol Med (1988) 1.22
Prenatal exposure to famine and brain morphology in schizophrenia. Am J Psychiatry (2000) 1.19
The Dutch famine and schizophrenia spectrum disorders. Soc Psychiatry Psychiatr Epidemiol (1998) 1.19
Psychiatric bed utilization: 1896 and 1996 compared. Psychol Med (2001) 1.18
Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors. J Med Chem (1989) 1.13
Schizoid personality disorder after prenatal exposure to famine. Am J Psychiatry (1996) 1.09
Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry (2000) 1.09
A critical time intervention with mentally ill homeless men: impact on psychiatric symptoms. J Nerv Ment Dis (2000) 1.07
Qualitative and quantitative estimates of apoptosis from birth to senescence in the rat brain. Cell Death Differ (2001) 1.05
Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol (2012) 1.05
Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol (1999) 1.04
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol (2013) 1.04
Low-level lifetime lead exposure produces behavioral toxicity (spatial discrimination reversal) in adult monkeys. Toxicol Appl Pharmacol (1987) 1.02
The rationale for a national prospective cohort study of environmental exposure and childhood development. Environ Res (2001) 1.02
Controlling tuberculosis in an urban emergency department: a rapid decision instrument for patient isolation. Am J Public Health (1997) 1.01
The use of well controls: an unhealthy practice in psychiatric research. Psychol Med (2011) 1.01
Gestational exposure to chlorpyrifos: apparent protection of the fetus? Toxicol Appl Pharmacol (1998) 1.00
Tuberculosis infection among people with severe mental illness. Psychiatr Serv (1997) 0.99
Social integration in global mental health: what is it and how can it be measured? Epidemiol Psychiatr Sci (2012) 0.98
Risk factors for a causal intermediate and an endpoint: reconciling differences. Am J Epidemiol (2000) 0.98
Duration of remitting psychoses with acute onset. Implications for ICD-10. Br J Psychiatry (2000) 0.98
Ketoconazole therapy for endemic blastomycosis. Ann Intern Med (1985) 0.97
Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain. Neuroscience (2001) 0.97
Psychosis in migrant and minority populations: prescriptions for scientific and social policy. Psychol Med (2009) 0.95
Early chronic low-level methylmercury poisoning in monkeys impairs spatial vision. Science (1982) 0.94
Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors. J Med Chem (1989) 0.93
Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol (2001) 0.93
Fate of the TRAM flap after abdominoplasty in a rat model. Plast Reconstr Surg (1998) 0.92
Cocaine and development: clinical, behavioral, and neurobiological perspectives--a symposium report. Neurotoxicol Teratol (1999) 0.91
Disruption of cerebellar maturation by an antimitotic agent impairs the ontogeny of eyeblink conditioning in rats. J Neurosci (1995) 0.91
Severe bereavement stress during the prenatal and childhood periods and risk of psychosis in later life: population based cohort study. BMJ (2014) 0.91
Control for environmental risk factors in assessing genetic effects on disease familial aggregation. Am J Epidemiol (1991) 0.91
Schizophrenia and prenatal exposure to the 1957 A2 influenza epidemic in Croatia. Am J Psychiatry (1994) 0.90
Topics for our times: can we learn from the care of persons with mental illness in developing countries? Am J Public Health (1996) 0.90
Course and outcome of acute non-organic psychotic states in India. Psychiatr Q (1996) 0.90
Gains and losses of the XII-VII component of the "baby-sitter" procedure: a morphometric analysis. J Reconstr Microsurg (1998) 0.89
Disposition of inhaled mercury vapor in pregnant rats: maternal toxicity and effects on developmental outcome. Toxicol Sci (2002) 0.89
Repeated exposure of adult rats to Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol (1998) 0.89
Reasons given for disclosure of maternal HIV status to children. J Urban Health (2000) 0.88
Development of blobs in the visual cortex of macaques. J Comp Neurol (1993) 0.88
The parent disclosure interview. AIDS Care (1999) 0.88
Adverse pregnancy outcome in the monkey (Macaca fascicularis) after chronic caffeine exposure. J Pharmacol Exp Ther (1988) 0.87
Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology (2001) 0.87
Reliability of post-mortem chart diagnoses of schizophrenia and dementia. Schizophr Res (1995) 0.86
Effects of in utero methylmercury exposure on a spatial delayed alternation task in monkeys. Toxicol Appl Pharmacol (1993) 0.86
Anthrax in animals and a farmer in Alto Adige, Italy. Euro Surveill (2006) 0.86
Effects of methylmercury and mercuric chloride on differentiation and cell viability in PC12 cells. Toxicol Sci (2001) 0.86
A preliminary cost effectiveness analysis of an intervention to reduce homelessness among the mentally ill. Psychiatr Q (1994) 0.86
Chronic low-lead exposure from birth produces deficits in discrimination reversal in monkeys. Toxicol Appl Pharmacol (1985) 0.85
Adenosine analogs with covalently attached lipids have enhanced potency at A1-adenosine receptors. FEBS Lett (1987) 0.85
Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus (2011) 0.84
Accumulation of methylmercury or polychlorinated biphenyls in in vitro models of rat neuronal tissue. Toxicol Appl Pharmacol (2004) 0.84
Tuberculosis and HIV among mentally ill men in a New York City shelter. Am J Public Health (1996) 0.84
Fixed interval/fixed ratio performance in adult monkeys exposed in utero to methylmercury. Neurotoxicol Teratol (1997) 0.84
Analysis of collagen content in the fetal wound. Ann Plast Surg (1988) 0.83
Lack of relation between culture and anorexia nervosa--results of an incidence study on Curaçao. N Engl J Med (1998) 0.83
Behavioral assessments of learning and attention in rats exposed perinatally to 3,3',4,4',5-pentachlorobiphenyl (PCB 126) Neurotoxicol Teratol (1999) 0.83
Early experience with the new 'megacoupler' ring-pins for microvascular anastomoses. J Plast Reconstr Aesthet Surg (2008) 0.83
Preserving public health values. Epidemiology (1999) 0.83
Effects of chronic developmental lead exposure on monkey neuroanatomy: visual system. Toxicol Appl Pharmacol (1989) 0.83
Developing anticipatory guidance programs based on early assessment of infant temperament: two tests of a prevention model. J Pediatr Psychol (1986) 0.83
Assessment of mercury neurotoxicity through psychometric and neurobehavioral testing: session summary. Neurotoxicology (1996) 0.83
Behavioral deficit (delayed matching to sample) in monkeys exposed from birth to low levels of lead. Toxicol Appl Pharmacol (1984) 0.83
Low-frequency hearing loss following perinatal exposure to 3,3',4,4',5-pentachlorobiphenyl (PCB 126) in rats. Neurotoxicol Teratol (1999) 0.83
Sperm chromatin structure is altered in cynomolgus monkeys with environmentally relevant blood lead levels. Toxicol Ind Health (1997) 0.82
Neonatal low-level lead exposure in monkeys: locomotor activity, schedule-controlled behavior, and the effects of amphetamine. Toxicol Appl Pharmacol (1979) 0.82
Fenthion produces a persistent decrease in muscarinic receptor function in the adult rat retina. Toxicol Appl Pharmacol (1994) 0.82
Methods for successful follow-up of elusive urban populations: an ethnographic approach with homeless men. Bull N Y Acad Med (1997) 0.81
Cognitive and neuroanatomical effects of triethyltin in developing rats: role of age of exposure. Brain Res (1994) 0.81
Low lead exposure from birth produces behavioral toxicity (DRL) in monkeys. Toxicol Appl Pharmacol (1985) 0.81
Effects of gestational methylmercury exposure on immunoreactivity of specific isoforms of PKC and enzyme activity during post-natal development of the rat brain. Brain Res Dev Brain Res (1998) 0.81
Mortality and long-term course in schizophrenia with a poor 2-year course: a study in a developing country. Br J Psychiatry (2001) 0.81
Reproductive endocrine effects of chronic lead exposure in the male cynomolgus monkey. Reprod Toxicol (1993) 0.81
Gestational exposure to chlorpyrifos: dose response profiles for cholinesterase and carboxylesterase activity. Toxicol Sci (1999) 0.81
The impact of substance dependence on HIV sexual risk-reduction among men with severe mental illness. AIDS Care (2005) 0.80